vs

Side-by-side financial comparison of AbbVie (ABBV) and General Dynamics (GD). Click either name above to swap in a different company.

AbbVie is the larger business by last-quarter revenue ($15.0B vs $13.5B, roughly 1.1× General Dynamics). General Dynamics runs the higher net margin — 8.3% vs 4.6%, a 3.7% gap on every dollar of revenue. On growth, General Dynamics posted the faster year-over-year revenue change (10.3% vs 9.9%). Over the past eight quarters, General Dynamics's revenue compounded faster (6.1% CAGR vs 1.8%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

General Dynamics Corporation (GD) is an American industrial and technology company based in Reston, Virginia. It is primarily a developer and producer of advanced military equipment of a wide variety, such as nuclear submarines, main battle tanks, and armoured fighting vehicles. It is also the manufacturer of the civilian aviation Gulfstream business jets and a provider of information technology services. The company is the 3rd largest of the top 100 contractors of the U.S.

ABBV vs GD — Head-to-Head

Bigger by revenue
ABBV
ABBV
1.1× larger
ABBV
$15.0B
$13.5B
GD
Growing faster (revenue YoY)
GD
GD
+0.4% gap
GD
10.3%
9.9%
ABBV
Higher net margin
GD
GD
3.7% more per $
GD
8.3%
4.6%
ABBV
Faster 2-yr revenue CAGR
GD
GD
Annualised
GD
6.1%
1.8%
ABBV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ABBV
ABBV
GD
GD
Revenue
$15.0B
$13.5B
Net Profit
$697.0M
$1.1B
Gross Margin
Operating Margin
26.6%
10.5%
Net Margin
4.6%
8.3%
Revenue YoY
9.9%
10.3%
Net Profit YoY
-45.9%
758.8%
EPS (diluted)
$0.39
$4.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
GD
GD
Q1 26
$15.0B
$13.5B
Q4 25
$16.6B
$14.4B
Q3 25
$15.8B
$12.9B
Q2 25
$15.4B
$13.0B
Q1 25
$13.3B
$12.2B
Q4 24
$15.1B
$13.3B
Q3 24
$14.5B
$11.7B
Q2 24
$14.5B
$12.0B
Net Profit
ABBV
ABBV
GD
GD
Q1 26
$697.0M
$1.1B
Q4 25
$1.8B
$1.1B
Q3 25
$186.0M
$1.1B
Q2 25
$938.0M
$1.0B
Q1 25
$1.3B
$994.0M
Q4 24
$-22.0M
$1.1B
Q3 24
$1.6B
$930.0M
Q2 24
$1.4B
$905.0M
Gross Margin
ABBV
ABBV
GD
GD
Q1 26
Q4 25
72.6%
Q3 25
66.4%
Q2 25
71.8%
Q1 25
70.0%
Q4 24
70.9%
Q3 24
70.9%
Q2 24
70.9%
Operating Margin
ABBV
ABBV
GD
GD
Q1 26
26.6%
10.5%
Q4 25
27.3%
10.1%
Q3 25
12.1%
10.3%
Q2 25
31.7%
10.0%
Q1 25
28.0%
10.4%
Q4 24
-9.9%
10.7%
Q3 24
26.5%
10.1%
Q2 24
27.6%
9.7%
Net Margin
ABBV
ABBV
GD
GD
Q1 26
4.6%
8.3%
Q4 25
10.9%
7.9%
Q3 25
1.2%
8.2%
Q2 25
6.1%
7.8%
Q1 25
9.6%
8.1%
Q4 24
-0.1%
8.6%
Q3 24
10.8%
8.0%
Q2 24
9.5%
7.6%
EPS (diluted)
ABBV
ABBV
GD
GD
Q1 26
$0.39
$4.10
Q4 25
$1.02
Q3 25
$0.10
Q2 25
$0.52
Q1 25
$0.72
Q4 24
$-0.03
Q3 24
$0.88
Q2 24
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
GD
GD
Cash + ST InvestmentsLiquidity on hand
$3.7B
Total DebtLower is stronger
$6.3B
Stockholders' EquityBook value
$26.1B
Total Assets
$59.0B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
GD
GD
Q1 26
$3.7B
Q4 25
$5.3B
$2.3B
Q3 25
$5.7B
$2.5B
Q2 25
$6.5B
$1.5B
Q1 25
$5.2B
$1.2B
Q4 24
$5.6B
$1.7B
Q3 24
$7.3B
$2.1B
Q2 24
$13.2B
$1.4B
Total Debt
ABBV
ABBV
GD
GD
Q1 26
$6.3B
Q4 25
$58.9B
$8.1B
Q3 25
$63.0B
Q2 25
$63.0B
Q1 25
$64.5B
Q4 24
$60.3B
$8.8B
Q3 24
$58.5B
Q2 24
$58.0B
Stockholders' Equity
ABBV
ABBV
GD
GD
Q1 26
$26.1B
Q4 25
$-3.3B
$25.6B
Q3 25
$-2.6B
$24.4B
Q2 25
$-183.0M
$23.6B
Q1 25
$1.4B
$22.2B
Q4 24
$3.3B
$22.1B
Q3 24
$6.0B
$23.0B
Q2 24
$6.8B
$22.0B
Total Assets
ABBV
ABBV
GD
GD
Q1 26
$59.0B
Q4 25
$134.0B
$57.2B
Q3 25
$133.9B
$57.6B
Q2 25
$137.2B
$56.9B
Q1 25
$136.2B
$56.6B
Q4 24
$135.2B
$55.9B
Q3 24
$143.4B
$57.3B
Q2 24
$141.9B
$55.4B
Debt / Equity
ABBV
ABBV
GD
GD
Q1 26
0.24×
Q4 25
0.32×
Q3 25
Q2 25
Q1 25
45.44×
Q4 24
18.15×
0.40×
Q3 24
9.70×
Q2 24
8.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
GD
GD
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$2.0B
FCF MarginFCF / Revenue
14.5%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$6.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
GD
GD
Q1 26
Q4 25
$5.2B
$1.6B
Q3 25
$7.0B
$2.1B
Q2 25
$5.2B
$1.6B
Q1 25
$1.6B
$-148.0M
Q4 24
$7.0B
$2.2B
Q3 24
$5.4B
$1.4B
Q2 24
$2.3B
$814.0M
Free Cash Flow
ABBV
ABBV
GD
GD
Q1 26
$2.0B
Q4 25
$4.9B
$952.0M
Q3 25
$6.6B
$1.9B
Q2 25
$4.9B
$1.4B
Q1 25
$1.4B
$-290.0M
Q4 24
$6.8B
$1.8B
Q3 24
$5.2B
$1.2B
Q2 24
$2.0B
$613.0M
FCF Margin
ABBV
ABBV
GD
GD
Q1 26
14.5%
Q4 25
29.4%
6.6%
Q3 25
42.1%
14.7%
Q2 25
31.7%
10.7%
Q1 25
10.5%
-2.4%
Q4 24
44.7%
13.5%
Q3 24
35.9%
10.4%
Q2 24
14.0%
5.1%
Capex Intensity
ABBV
ABBV
GD
GD
Q1 26
1.5%
Q4 25
2.0%
4.2%
Q3 25
2.4%
1.6%
Q2 25
1.7%
1.5%
Q1 25
1.8%
1.2%
Q4 24
1.9%
2.7%
Q3 24
1.7%
1.7%
Q2 24
1.7%
1.7%
Cash Conversion
ABBV
ABBV
GD
GD
Q1 26
Q4 25
2.87×
1.37×
Q3 25
37.76×
1.99×
Q2 25
5.49×
1.58×
Q1 25
1.27×
-0.15×
Q4 24
1.88×
Q3 24
3.49×
1.52×
Q2 24
1.66×
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons